Cite
Patent Issued for Thienopyrimidine and thienopyridine compounds and methods of use thereof (USPTO RE049687).
MLA
“Patent Issued for Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof (USPTO RE049687).” Cancer Weekly, Oct. 2023, p. 2063. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=173221355&authtype=sso&custid=ns315887.
APA
Patent Issued for Thienopyrimidine and thienopyridine compounds and methods of use thereof (USPTO RE049687). (2023). Cancer Weekly, 2063.
Chicago
“Patent Issued for Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof (USPTO RE049687).” 2023. Cancer Weekly, October, 2063. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=173221355&authtype=sso&custid=ns315887.